• Brand Engagement Network entered a collaboration with Grupo Skye and KNOBLOCH Information Group to develop and evaluate Skye Salud in Mexico.
• Skye Salud, an AI medical evidence platform, moved to Phase 2 clinical evaluation in Mexico following successful Phase 1 rheumatology testing.
• Phase 2 expands testing into primary care, adding Spanish-language clinical content tailored to the Mexican healthcare system.
• Partners will use Phase 2 results to guide product development, commercialization planning, potential expansion across Mexico and Latin America.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Brand Engagement Network Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202606230600PR_NEWS_USPR_____PH89895) on June 23, 2026, and is solely responsible for the information contained therein.